Ligand validation:5QDA

E74: (4S)-4-[(1R)-1-hydroxy-2-({[3-(propan-2-yl)phenyl]methyl}amino)ethyl]-18-methoxy-3,15,17-triazatricyclo[14.3.1.1~6,10~]henicosa-1(20),6(21),7,9,16,18-hexaen-2-one

E74 is a Ligand Of Interest in 5QDA designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5QDA_E74_C_401	75%	71%	0.121	0.953	0.47	0.64	-	1	0	0	100%	0.9868
5QDA_E74_B_401	49%	72%	0.177	0.926	0.43	0.66	-	1	0	0	100%	0.9605
5QDA_E74_A_401	47%	78%	0.202	0.944	0.37	0.52	-	-	0	0	100%	0.9605

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.